| Product Code: ETC11831694 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cell Gene Therapy CDMO Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cell Gene Therapy CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 India Cell Gene Therapy CDMO Market - Industry Life Cycle |
3.4 India Cell Gene Therapy CDMO Market - Porter's Five Forces |
3.5 India Cell Gene Therapy CDMO Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 India Cell Gene Therapy CDMO Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 India Cell Gene Therapy CDMO Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 India Cell Gene Therapy CDMO Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 India Cell Gene Therapy CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of genetic disorders and chronic diseases in India |
4.2.2 Growing investments in healthcare infrastructure and research development |
4.2.3 Rising demand for personalized medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements and approval processes |
4.3.2 Limited awareness and understanding of cell gene therapy among healthcare professionals and patients |
4.3.3 High costs associated with cell gene therapy treatments |
5 India Cell Gene Therapy CDMO Market Trends |
6 India Cell Gene Therapy CDMO Market, By Types |
6.1 India Cell Gene Therapy CDMO Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 India Cell Gene Therapy CDMO Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 India Cell Gene Therapy CDMO Market Revenues & Volume, By Viral Vector Manufacturing, 2021 - 2031F |
6.1.4 India Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid DNA Manufacturing, 2021 - 2031F |
6.1.5 India Cell Gene Therapy CDMO Market Revenues & Volume, By Cell Therapy Manufacturing, 2021 - 2031F |
6.1.6 India Cell Gene Therapy CDMO Market Revenues & Volume, By Cryopreservation Services, 2021 - 2031F |
6.2 India Cell Gene Therapy CDMO Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 India Cell Gene Therapy CDMO Market Revenues & Volume, By Lentiviral Vector Technology, 2021 - 2031F |
6.2.3 India Cell Gene Therapy CDMO Market Revenues & Volume, By Plasmid-Based Gene Delivery, 2021 - 2031F |
6.2.4 India Cell Gene Therapy CDMO Market Revenues & Volume, By CAR-T Cell Expansion Technology, 2021 - 2031F |
6.2.5 India Cell Gene Therapy CDMO Market Revenues & Volume, By Controlled-Rate Freezing, 2021 - 2031F |
6.3 India Cell Gene Therapy CDMO Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 India Cell Gene Therapy CDMO Market Revenues & Volume, By Biopharmaceutical Companies, 2021 - 2031F |
6.3.3 India Cell Gene Therapy CDMO Market Revenues & Volume, By Research Institutes, 2021 - 2031F |
6.3.4 India Cell Gene Therapy CDMO Market Revenues & Volume, By Hospitals and Clinics, 2021 - 2031F |
6.3.5 India Cell Gene Therapy CDMO Market Revenues & Volume, By Cell and Gene Therapy Developers, 2021 - 2031F |
6.4 India Cell Gene Therapy CDMO Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 India Cell Gene Therapy CDMO Market Revenues & Volume, By Gene Delivery for Cell Therapy, 2021 - 2031F |
6.4.3 India Cell Gene Therapy CDMO Market Revenues & Volume, By Preclinical and Clinical Studies, 2021 - 2031F |
6.4.4 India Cell Gene Therapy CDMO Market Revenues & Volume, By Oncology and Rare Diseases Treatment, 2021 - 2031F |
6.4.5 India Cell Gene Therapy CDMO Market Revenues & Volume, By Transport of Cell Therapies, 2021 - 2031F |
7 India Cell Gene Therapy CDMO Market Import-Export Trade Statistics |
7.1 India Cell Gene Therapy CDMO Market Export to Major Countries |
7.2 India Cell Gene Therapy CDMO Market Imports from Major Countries |
8 India Cell Gene Therapy CDMO Market Key Performance Indicators |
8.1 Number of clinical trials and research studies conducted in the field of cell gene therapy in India |
8.2 Adoption rate of cell gene therapy services by hospitals and healthcare facilities |
8.3 Number of partnerships and collaborations between biotech companies and academic institutions for cell gene therapy research |
9 India Cell Gene Therapy CDMO Market - Opportunity Assessment |
9.1 India Cell Gene Therapy CDMO Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 India Cell Gene Therapy CDMO Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 India Cell Gene Therapy CDMO Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 India Cell Gene Therapy CDMO Market Opportunity Assessment, By Application, 2021 & 2031F |
10 India Cell Gene Therapy CDMO Market - Competitive Landscape |
10.1 India Cell Gene Therapy CDMO Market Revenue Share, By Companies, 2024 |
10.2 India Cell Gene Therapy CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here